Interferon therapy in hepatitis C leading to chronic type 1 diabetes

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

(2014) Mark S. Sulkowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase 2b Trial of Interferon-free Therapy for Hepatitis C Virus Genotype 1

(2014) Kris V. Kowdley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Extensive Psoriasis Induced by Pegylated Interferon Alfa-2a and Ribavirin in the Treatment of Chronic Hepatitis C

(2013) Gun-Wook Kim et al.   Annals of Dermatology

Evaluation of liver disease progression in the German hepatitis C virus (1b)-contaminated anti-D cohort at 35 years after infection

(2013) Manfred Wiese et al.   HEPATOLOGY

Is there sufficient evidence to recommend antiviral therapy in hepatitis C?

(2013) Adriaan J. van der Meer et al.   JOURNAL OF HEPATOLOGY

The Hepatitis C Virus Modulates Insulin Signaling Pathway In Vitro Promoting Insulin Resistance

(2012) José A. del Campo et al.   PLoS One

Relationship between hepatitis C virus infection and type 2 diabetes mellitus: Meta-analysis

(2012) Cho Naing   WORLD JOURNAL OF GASTROENTEROLOGY

Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus

(2011) Hiroaki Yagyu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

A case of chronic hepatitis C developing insulin-dependent diabetes, thyroid autoimmunity and stiff-person syndrome as complications of interferon therapy

(2010) G. Scavone et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Dual onset of type 1 diabetes mellitus and Graves’ disease during treatment with pegylated interferon α-2b and ribavirin for chronic hepatitis C

(2009) Masayuki Hayashi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Safety of peginterferon in the treatment of chronic hepatitis C

(2008) Nikroo Hashemi et al.   Expert Opinion On Drug Safety